This International Immunosuppression Summit 2016 will bring together scientists to discuss the problems associated with natural and induced immunosuppression.
A late registration fee applies after January 20th 2016
Who should attend
This summit will interest those working in drug design and discovery, physicians and clinicians, research scientists and academics, and those who work within the industry.
This event has an open abstract session.
Abstracts can be submitted on any subject related to Immunosuppression and Immunotherapy.
The Deadline for abstract submissions for oral presentation is December 10th 2015
Abstracts for poster presentation only can be submitted up to two weeks before the event You can download the instructions for authors at www.euroscicon.com/ABSTRACTSUBMISSIONS.pdf
Five years from now, the Food and Drug Administration expects it will be clearing 10 to 20 cell and gene therapy products a year. Yet while the arrival of gene therapy's moment may be clear, its effects on a healthcare system designed around chronic treatment are not. INCLUDED IN THIS TRENDLINE Trends and challenges in the […]